Skip to content

Inspection Record

Omrix Biopharmaceuticals Ltd. — FDA 483 Findings

US FDAInspected 2020-03-05Published 2026-10-26 4 findingsLaboratory and QC controlsDocumentation and records

Inspectors Mihaly S Ligmond · Steven E Bowen · Chava Kimchi SarfatyThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.

2Laboratory and QC controls

Established laboratory control mechanisms are not documented at the time ofperformance.

3Documentation and records

Batch production and control records do not include complete labeling control records, including specimens or copies of all labeling used for each batch of drug product produced.

4Laboratory and QC controls

Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Omrix Biopharmaceuticals Ltd. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.